Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure

Publication date: June 2018
Source:European Journal of Cancer, Volume 96
Author(s): Andrea Necchi, Daniele Raggi, Patrizia Giannatempo, Alessandra Alessi, Gianluca Serafini, Maurizio Colecchia, Siraj M. Ali, Jon H. Chung




from Cancer via ola Kala on Inoreader https://ift.tt/2rCJ2vv
via IFTTT